RxDoctor Payments Data

Jennifer Jackson, DO

Nephrology · Dayton, OHNPI 1275507311

Payments from drug & device makers

$1,238in general payments, 2019–2025

Across 65 payments — averaging $19.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$272
  • Travere Therapeutics, Inc.$138
  • OPKO Pharmaceuticals, LLC$132
  • Nxstage Medical, Inc.$131
  • Bayer$108
  • Novartis$91
  • plus $367 from 11 others

What the payments were for

  • Food & beverage$1,04985%
  • Education$18915%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,238 in reported general payments places this provider in the 50th percentile of 450 nephrology providers in Ohio.

See all nephrology providers in Ohio

Medicare billing

Part B allowed, 2024
$173,560
Medicare patients
493
Services billed
1,756

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol33$36,947
RayaldeeCalcifediol12$14,643
Sevelamer Carbonate41$9,810
LokelmaSodium Zirconium Cyclosilicate11$8,116
Calcium Acetate12$2,199
Calcitriol108$1,907
Nifedipine ErNifedipine27$1,398
Bumetanide20$1,271
Potassium Chloride37$845
Torsemide20$688
Klor-Con M20Potassium Chloride24$580
Losartan Potassium74$542
Carvedilol68$537
Furosemide111$525
Hydralazine Hcl33$321

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Lokelma$272$45,06244 claims
OPKO Pharmaceuticals, LLCRayaldee$132$14,64312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 450 nephrology providers in Ohio.

Other nephrology in Dayton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →